Literature DB >> 17893158

BK Virus replication in vitro: limited effect of drugs interfering with viral uptake and intracellular transport.

Parmjeet Randhawa1, Noush Afarin Farasati, Yuchen Huang.   

Abstract

BK virus is an important pathogen in kidney transplant recipients. In vitro studies demonstrated slight antiviral activity for chloroquine and nystatin. A sialic acid derivative, BTB11968, was identified as a lead compound for further development.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17893158      PMCID： PMC2168003          DOI： 10.1128/AAC.00843-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  19 in total

1.  Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae.

Authors:  H A Anderson; Y Chen; L C Norkin
Journal:  Mol Biol Cell       Date:  1996-11       Impact factor: 4.138

2.  Intrarenal serotonin, dopamine, and phosphate handling in remnant kidneys.

Authors:  T J Berndt; M Liang; G M Tyce; F G Knox
Journal:  Kidney Int       Date:  2001-02       Impact factor: 10.612

3.  Inhibition of human immunodeficiency virus infectivity by chloroquine.

Authors:  W P Tsai; P L Nara; H F Kung; S Oroszlan
Journal:  AIDS Res Hum Retroviruses       Date:  1990-04       Impact factor: 2.205

4.  The human polyomavirus, JCV, uses serotonin receptors to infect cells.

Authors:  Gwendolyn F Elphick; William Querbes; Joslynn A Jordan; Gretchen V Gee; Sylvia Eash; Kate Manley; Aisling Dugan; Megan Stanifer; Anushree Bhatnagar; Wesley K Kroeze; Bryan L Roth; Walter J Atwood
Journal:  Science       Date:  2004-11-19       Impact factor: 47.728

5.  Actin disruption inhibits endosomal traffic of P-glycoprotein-EGFP and resistance to daunorubicin accumulation.

Authors:  Dong Fu; Basil D Roufogalis
Journal:  Am J Physiol Cell Physiol       Date:  2006-11-22       Impact factor: 4.249

6.  Prevalence of JC virus viraemia in HIV-infected patients with or without neurological disorders: a prospective study.

Authors:  V Dubois; H Moret; M E Lafon; C B Janvresse; E Dussaix; J Icart; A Karaterki; A Ruffault; Y Taoufik; C Vignoli; D Ingrand
Journal:  J Neurovirol       Date:  1998-10       Impact factor: 2.643

7.  Mechanism of uncoating of influenza B virus in MDCK cells: action of chloroquine.

Authors:  M Shibata; H Aoki; T Tsurumi; Y Sugiura; Y Nishiyama; S Suzuki; K Maeno
Journal:  J Gen Virol       Date:  1983-05       Impact factor: 3.891

8.  Quantitation of viral DNA in renal allograft tissue from patients with BK virus nephropathy.

Authors:  Parmjeet S Randhawa; Abhay Vats; Deborah Zygmunt; Patricia Swalsky; Velma Scantlebury; Ron Shapiro; Sydney Finkelstein
Journal:  Transplantation       Date:  2002-08-27       Impact factor: 4.939

Review 9.  Effects of chloroquine on viral infections: an old drug against today's diseases?

Authors:  Andrea Savarino; Johan R Boelaert; Antonio Cassone; Giancarlo Majori; Roberto Cauda
Journal:  Lancet Infect Dis       Date:  2003-11       Impact factor: 25.071

10.  In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine.

Authors:  Els Keyaerts; Leen Vijgen; Piet Maes; Johan Neyts; Marc Van Ranst
Journal:  Biochem Biophys Res Commun       Date:  2004-10-08       Impact factor: 3.575
View more
  2 in total

1.  Viral drug sensitivity testing using quantitative PCR: effect of tyrosine kinase inhibitors on polyomavirus BK replication.

Authors:  Parmjeet S Randhawa; Noush A Farasati; Yuchen Huang; Markus Y Mapara; Ron Shapiro
Journal:  Am J Clin Pathol       Date:  2010-12       Impact factor: 2.493

2.  The Oxysterol 25-Hydroxycholesterol Inhibits Replication of Murine Norovirus.

Authors:  Ghada T Shawli; Oluwapelumi O Adeyemi; Nicola J Stonehouse; Morgan R Herod
Journal:  Viruses       Date:  2019-01-24       Impact factor: 5.048
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.